Latest On Correvio Pharma Corp (CORV):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-09-19 08:41 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-09-17 04:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 20:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 00:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 16:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-10 08:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 08:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-02 16:36 EST | Analyst Rating | The Analyst Target Price has increased from $1.08 to $1.75. | Buy | |
| 2020-05-31 16:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-05 00:42 EST | News | Correvio postpones Q1 results due to COVID-19 | N/A | |
| 2020-05-03 08:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-11 08:43 EST | News | Correvio up 41% on Aggrastat deal in Asia | N/A | |
| 2020-04-11 08:38 EST | News | Advanz Pharma to buy Correvio Pharma for $76M | N/A | |
| 2020-04-11 08:19 EST | News | Correvio Pharma EPS misses by $0.01, misses on revenue | N/A | |
| 2020-04-07 12:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-07 00:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-07 00:37 EST | Earnings Estimate | An EPS average of -$0.18 is estimated for the 2021 year. | Sell | |
| 2020-04-07 00:37 EST | Earnings Estimate | An EPS average of -$0.09 is estimated for the quarter ending on June 30, 2020. | Sell | |
| 2020-04-06 04:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-02 04:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-18 00:25 EST | Analyst Rating | The Analyst Target Price has decreased from $3.12 to $1.08. | Neutral | |
| 2020-02-28 23:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 03:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 03:30 EST | Earnings | Earnings have been released on May 16, 2017, with -$0.20 earnings per share. | Sell | |
| 2020-02-21 23:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-14 23:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-06 23:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-29 23:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-28 03:31 EST | Earnings | Earnings have been released on November 14, 2019, with -$0.23 earnings per share. | Sell | |
| 2020-01-28 03:31 EST | Earnings | Earnings have been released on May 8, 2019, with -$0.23 earnings per share. | Sell | |
| 2020-01-28 03:31 EST | Earnings | Earnings have been released on March 13, 2019, with -$0.18 earnings per share. | Buy | |
| 2020-01-28 03:31 EST | Earnings | Earnings have been released on November 15, 2017, with -$0.20 earnings per share. | Sell | |
| 2020-01-27 23:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-15 23:25 EST | Financials | Company financials have been released. | Neutral | |
| 2019-12-24 09:23 EST | News | CORV -1.5% on FDA complete response letter | N/A | |
| 2019-12-21 23:16 EST | Financials | Company financials have been released. | Neutral | |
| 2019-12-21 08:30 EST | News | Stocks To Watch: Amazon To Star On Boxing Day | N/A | |
| 2019-12-17 03:15 EST | Analyst Rating | The Analyst Target Price has decreased from $4.74 to $3.12. | Neutral | |
| 2019-12-16 23:24 EST | Financials | Company financials have been released. | Neutral | |
| 2019-12-16 11:11 EST | News | Goldman likes Amgen and UnitedHealth Group in premarket analyst action | N/A | |
| 2019-12-11 12:52 EST | News | GME, AEO among premarket losers | N/A | |
| 2019-12-11 12:51 EST | News | Microbot Medical leads healthcare gainers; Correvio Pharma tops the losers | N/A | |
| 2019-12-11 12:51 EST | News | GME, MDGL, MBOT and OLLI among midday movers | N/A | |
| 2019-12-11 09:05 EST | News | Wells cuts view on Cigna in premarket analyst action | N/A | |
| 2019-12-11 09:05 EST | News | Correvio to explore strategic alternatives after Ad Com snub of Brinavess for AF | N/A | |
| 2019-12-10 18:19 EST | News | FDA advisory committee thumbs down on Correvio's Brinavess for AF | N/A | |
| 2019-12-10 08:45 EST | News | Correvio shares halted for Ad Com review of Brinavess for AF | N/A | |
| 2019-12-10 03:16 EST | Analyst Rating | The Analyst Target Price has decreased from $5.84 to $4.74. | Neutral | |
| 2019-12-09 09:22 EST | News | BLUE, PCG among premarket gainers | N/A | |
| 2019-12-06 14:00 EST | News | TRNX, YEXT, BIG and CGIX among midday movers | N/A | |
About Correvio Pharma Corp (CORV):
Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide. Its products comprise Aggrastat (tirofiban hydrochloride), (an intravenous anti-platelet drug for patients with acute coronary syndrome; and Brinavess (vernakalant IV), a novel, atrial-preferential antiarrhythmic agent for the rapid conversion of recent onset atrial fibrillation to sinus rhythm. The company also offers Trevyent, a development stage drug/device combination product for pulmonary arterial hypertension; Xydalba, a treatment for acute bacterial skin and skin structure infections; and Zevtera/Mabelio, a cephalosporin antibiotic for intravenous administration with rapid bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria. Correvio Pharma Corp. was incorporated in 2018 and is headquartered in Vancouver, Canada.
General
- Name Correvio Pharma Corp
- Symbol CORV
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers—Specialty & Generic
- Full Time Employees 133
- Last Split Factor1:5
- Last Split Date2013-04-12
- Fiscal Year EndDecember
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.correvio.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 0.57
- Price/Book (Most Recent Quarter) 10.46
- Enterprise Value Revenue 1.89
View More
Financials
- Most Recent Quarter 2019-12-31
- Current Year EPS Estimate -$0.31
- Next Year EPS Estimate -$0.06
- Profit Margin -108%
- Operating Margin -84%
- Return on Assets -29%
- Return on Equity -1158%
- Revenue 32.63 million
- Earnings Per Share -$0.88
- Revenue Per Share $0.74
- Gross Profit 22.81 million
- Quarterly Earnings Growth 26.6%
View More
Highlights
- Market Capitalization 27.79 million
- EBITDA -19143000
- Analyst Target Price $1.75
- Book Value Per Share $0.03
View More
Share Statistics
- Shares Outstanding 66.19 million
- Shares Float 61.32 million
- % Held by Insiders 724%
- % Held by Institutions 6.99%
- Shares Short 2.31 million
- Shares Short Prior Month 3.76 million
- Short Ratio 0.78
- Short % of Float 3%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 0.22
- 52 Week High $2.51
- 52 Week Low $0.25
- 50 Day Moving Average 0.41
- 200 Day Moving Average 0.4
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
View More
Correvio Pharma Corp (CORV) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Correvio Pharma Corp (CORV) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2019-12-31 | 2020-03-30 | $N/A | -$0.07 | -$0.12 | 41.67% |
| 2019-09-30 | 2019-11-14 | $6.67 million | -$0.23 | -$0.17 | -35.29% |
| 2019-06-30 | 2019-08-14 | $7.39 million | -$0.26 | -$0.23 | -13.04% |
| 2019-03-31 | 2019-05-08 | $7.25 million | -$0.23 | -$0.20 | -15% |
| 2018-12-31 | 2019-03-13 | $8.95 million | -$0.18 | -$0.21 | 15% |
| 2018-09-30 | 2018-11-07 | $7.01 million | -$0.20 | -$0.20 | -1.6% |
| 2018-06-30 | 2018-08-15 | $6.18 million | $0.16 | -$0.15 | 203.47% |
| 2018-03-31 | 2018-05-16 | $6.54 million | -$0.24 | -$0.08 | -205.13% |
| 2017-12-31 | 2018-03-14 | $7.03 million | -$0.24 | -$0.18 | -34.56% |
| 2017-09-30 | 2017-11-15 | $6.02 million | -$0.20 | -$0.18 | -10.67% |
| 2017-06-30 | 2017-08-09 | $5.75 million | -$0.26 | ||
| 2017-03-31 | 2017-05-16 | $5.2 million | -$0.20 | -$0.17 | -16.82% |
| 2016-12-31 | 2017-03-08 | $7.02 million | -$0.18 | ||
| 2016-09-30 | 2016-11-07 | $5.24 million | -$0.19 | ||
| 2016-06-30 | 2016-08-10 | $5.91 million | -$0.37 | ||
| 2016-03-31 | 2016-05-13 | $7.09 million | -$0.06 | ||
| 2015-12-31 | 2016-03-10 | $4.72 million | -$0.41 | ||
| 2015-09-30 | 2015-11-13 | $4.96 million | -$0.31 | ||
| 2015-06-30 | 2015-08-05 | $5.74 million | -$0.43 | ||
| 2015-03-31 | 2015-05-13 | $5.5 million | -$0.23 | ||
| 2014-12-31 | 2015-03-12 | $6.98 million | -$0.40 | ||
| 2014-09-30 | 2014-11-07 | $7.81 million | -$0.26 | ||
| 2014-06-30 | 2014-08-11 | $7.67 million | -$0.26 | ||
| 2014-03-31 | 2014-05-13 | $7.59 million | -$0.20 | ||
| 2013-12-31 | 2014-03-27 | $3.87 million | -$0.53 | ||
| 2013-09-30 | 2013-11-06 | $477000 | -$0.29 | ||
| 2013-06-30 | 2013-08-02 | $107000 | -$0.22 | ||
| 2013-03-31 | 2013-05-13 | $60000 | $1.47 | ||
| 2012-12-31 | 2013-03-15 | $84000 | $0.63 | ||
| 2012-09-30 | 2012-11-14 | $63000 | -$1.10 | ||
| 2012-06-30 | 2012-08-08 | $209000 | -$0.46 | ||
| 2012-03-31 | 2012-05-11 | $433000 | -$0.57 | ||
| 2011-12-31 | 2012-03-27 | $401000 | -$0.48 | ||
| 2011-09-30 | 2011-11-04 | $274000 | -$0.59 | ||
| 2011-06-30 | 2011-08-08 | $443000 | -$0.63 | ||
| 2011-03-31 | 2011-05-17 | $387000 | -$0.58 | ||
| 2010-12-31 | 2011-03-11 | $374000 | -$0.60 | ||
| 2010-09-30 | 2010-11-12 | $30.22 million | $1.84 | ||
| 2010-06-30 | 2010-08-11 | $12.42 million | $0.36 | ||
| 2010-03-31 | 2010-05-12 | $23.05 million | $1.23 | ||
| 2009-12-31 | 2010-03-10 | $23.53 million | $0.97 | ||
| 2009-09-30 | 2009-11-09 | $19.71 million | -$0.03 | ||
| 2009-06-30 | 2009-08-11 | $7.37 million | -$0.10 | ||
| 2009-03-31 | 2009-05-16 | $217287.87 | -$0.76 | ||
| 2008-12-31 | 2009-03-30 | $336949.38 | -$0.50 | ||
| 2008-09-30 | 2008-11-17 | $503522.78 | -$0.88 | ||
| 2008-06-30 | 2008-08-14 | $197825.87 | -$1.40 | ||
| 2008-03-31 | 2008-05-14 | $444401.13 | -$1.73 | ||
| 2007-12-31 | 2008-03-26 | $1.11 million | -$2.05 | ||
| 2007-09-30 | 2007-11-14 | $969238.53 | -$2.37 | ||
| 2007-06-30 | 2007-08-09 | $1.04 million | -$1.05 | ||
| 2007-03-31 | 2007-05-11 | $1.48 million | -$0.99 | ||
| 2006-12-31 | 2007-03-28 | $11.22 million | -$0.09 | ||
| 2006-09-30 | 2006-11-13 | $2.15 million | -$1.00 | ||
| 2006-06-30 | 2006-08-14 | $1.91 million | -$1.24 | ||
| 2006-03-31 | 2006-05-15 | $2.61 million | -$0.67 | ||
| 2005-09-30 | 2005-11-14 | $4.01 million | -$2.40 | ||
| 2005-06-30 | 2005-08-11 | $3.11 million | -$0.61 | ||
| 2005-03-31 | 2005-05-16 | $3.81 million | -$0.74 | ||
| 2004-12-31 | 2005-03-01 | $9.68 million | $0.20 | ||
| 2004-09-30 | 2004-11-15 | $3.57 million | -$1.45 | ||
| 2004-06-30 | 2004-08-12 | $3.95 million | -$0.92 | ||
| 2004-03-31 | 2004-05-16 | $3.81 million | -$0.48 |
Correvio Pharma Corp (CORV) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | N/A | N/A | N/A |
| Selling General Administrative | N/A | 11.19 million | 12.62 million | 11.19 million | 9.86 million |
| Gross Profit | N/A | 4.4 million | 4.98 million | 5.01 million | 7.05 million |
| Ebit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Income Tax Expense | 107000 | 15000 | 30000 | 27000 | N/A |
| Total Revenue | N/A | 6.67 million | 7.39 million | 7.25 million | 8.95 million |
| Cost of Revenue | N/A | 2.27 million | 2.41 million | 2.24 million | 1.9 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | N/A |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | N/A |
| Net Income Applicable to Common Shares | -4.94 million | N/A | N/A | N/A | N/A |
Cash Flow:
| Date | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | 976000 | N/A | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | -11000 | 226000 | 265000 | 110000 | 14.11 million |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | 23.33 million | 10.79 million | 7.94 million | 5.38 million |
| Change to Operating Activities | 113000 | N/A | N/A | N/A | N/A |
| Change in Cash | N/A | 2.1 million | N/A | 331000 | N/A |
| Total Cash from Operating Activities | -5.9 million | N/A | N/A | N/A | N/A |
| Depreciation | N/A | 2.94 million | 1.96 million | 984000 | 4.14 million |
| Other Cash Flow from Investing Activities | N/A | 376000 | 376000 | 190000 | 19.1 million |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | -269000 | N/A | N/A | N/A | N/A |
| Change to Net Income | 229000 | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 57.83 million | 58.97 million | 57.18 million | 52.73 million |
| Total Stockholder Equity | N/A | 1.54 million | N/A | 6.13 million | 6.91 million |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Assets | N/A | 59.37 million | 58.75 million | 63.31 million | 59.64 million |
| Common Stock | 385.06 million | 382.88 million | 370.49 million | 367.35 million | 359.3 million |
| Other Current Assets | N/A | 1.89 million | 1.97 million | 1.94 million | 1.97 million |
| Retained Earnings | -444.93 million | N/A | N/A | N/A | N/A |
| Other Liabilities | 1.23 million | N/A | N/A | N/A | N/A |
| Other Assets | 2.06 million | 1.98 million | 2.13 million | 2.04 million | 2.05 million |
| Cash | N/A | 17.79 million | 12.88 million | 15.96 million | 15.6 million |
| Total Current Liabilities | N/A | 21.97 million | 17.36 million | 11.82 million | 9.4 million |
| Other Stockholder Equity | 16.3 million | 16.34 million | 16.77 million | 16.56 million | 16.9 million |
| Property, Plant & Equipment | 2.51 million | 2.68 million | 2.76 million | 2.83 million | 512000 |
| Total Current Assets | N/A | 31.93 million | 29.13 million | 33.07 million | 30.29 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | -23.38 million | N/A | N/A | N/A | N/A |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | 33.07 million | 38.63 million | 42.32 million | 41.52 million |
| Inventory | N/A | 4.43 million | 3.93 million | 4.46 million | 4.16 million |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A |
Correvio Pharma Corp (CORV) Chart:
Correvio Pharma Corp (CORV) News:
Below you will find a list of latest news for Correvio Pharma Corp (CORV) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Correvio Pharma Corp (CORV) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Correvio Pharma Corp (CORV) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-09 | 15-12G | Securities registration termination [Section 12(g)] | https://www.sec.gov/Archives/edgar/data/1036141/000134100420000241/0001341004-20-000241-index.htm |
| 2019-01-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000089383819000005/0000893838-19-000005-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000093583619000105/0000935836-19-000105-index.htm |
| 2018-07-03 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000108514618001615/0001085146-18-001615-index.htm |
| 2019-04-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000108514619001081/0001085146-19-001081-index.htm |
| 2019-09-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000108514619002410/0001085146-19-002410-index.htm |
| 2020-01-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000108514620000013/0001085146-20-000013-index.htm |
| 2019-02-15 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000109544919000008/0001095449-19-000008-index.htm |
| 2019-02-15 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000109544919000010/0001095449-19-000010-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000109544920000019/0001095449-20-000019-index.htm |
| 2019-12-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000110465919075850/0001104659-19-075850-index.htm |
| 2019-12-26 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000110465919075852/0001104659-19-075852-index.htm |
| 2019-04-15 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000117625619000107/0001176256-19-000107-index.htm |
| 2019-05-03 | 6-K/A | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000117625619000135/0001176256-19-000135-index.htm |
| 2019-05-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000117625619000176/0001176256-19-000176-index.htm |
| 2020-03-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000117625620000081/0001176256-20-000081-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000119312519039677/0001193125-19-039677-index.htm |
| 2020-02-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000119312520045560/0001193125-20-045560-index.htm |
| 2020-04-30 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1036141/000119312520127179/0001193125-20-127179-index.htm |
| 2020-04-16 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000121465920003430/0001214659-20-003430-index.htm |
| 2020-05-26 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000121465920005020/0001214659-20-005020-index.htm |
| 2018-05-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001135/0001279569-18-001135-index.htm |
| 2018-06-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001260/0001279569-18-001260-index.htm |
| 2018-06-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001294/0001279569-18-001294-index.htm |
| 2018-06-25 | F-10 | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001344/0001279569-18-001344-index.htm |
| 2018-06-25 | F-X | Appointment of Agent for Service of Process and Undertaking | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001348/0001279569-18-001348-index.htm |
| 2018-07-05 | F-10/A | Registration Statement for Securities of certain Canadian Issuers. | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001414/0001279569-18-001414-index.htm |
| 2018-07-10 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001440/0001279569-18-001440-index.htm |
| 2018-07-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001444/0001279569-18-001444-index.htm |
| 2018-07-12 | 20-F/A | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001462/0001279569-18-001462-index.htm |
| 2018-07-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001516/0001279569-18-001516-index.htm |
| 2018-08-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001568/0001279569-18-001568-index.htm |
| 2018-08-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001620/0001279569-18-001620-index.htm |
| 2018-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001710/0001279569-18-001710-index.htm |
| 2018-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001713/0001279569-18-001713-index.htm |
| 2018-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001714/0001279569-18-001714-index.htm |
| 2018-08-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001735/0001279569-18-001735-index.htm |
| 2018-08-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001768/0001279569-18-001768-index.htm |
| 2018-09-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001790/0001279569-18-001790-index.htm |
| 2018-09-05 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001800/0001279569-18-001800-index.htm |
| 2018-09-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918001897/0001279569-18-001897-index.htm |
| 2018-10-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918002082/0001279569-18-002082-index.htm |
| 2018-10-29 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918002119/0001279569-18-002119-index.htm |
| 2018-10-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918002130/0001279569-18-002130-index.htm |
| 2018-11-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918002211/0001279569-18-002211-index.htm |
| 2018-11-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918002213/0001279569-18-002213-index.htm |
| 2018-11-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956918002332/0001279569-18-002332-index.htm |
| 2019-01-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000006/0001279569-19-000006-index.htm |
| 2019-01-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000056/0001279569-19-000056-index.htm |
| 2019-01-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000104/0001279569-19-000104-index.htm |
| 2019-02-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000230/0001279569-19-000230-index.htm |
| 2019-02-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000372/0001279569-19-000372-index.htm |
| 2019-03-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000499/0001279569-19-000499-index.htm |
| 2019-03-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000516/0001279569-19-000516-index.htm |
| 2019-03-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000535/0001279569-19-000535-index.htm |
| 2019-03-13 | 40-F | Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000563/0001279569-19-000563-index.htm |
| 2019-03-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000565/0001279569-19-000565-index.htm |
| 2019-03-14 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000574/0001279569-19-000574-index.htm |
| 2019-03-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000583/0001279569-19-000583-index.htm |
| 2019-03-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000622/0001279569-19-000622-index.htm |
| 2019-03-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000644/0001279569-19-000644-index.htm |
| 2019-04-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000803/0001279569-19-000803-index.htm |
| 2019-04-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000810/0001279569-19-000810-index.htm |
| 2019-04-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919000811/0001279569-19-000811-index.htm |
| 2019-05-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001011/0001279569-19-001011-index.htm |
| 2019-05-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001090/0001279569-19-001090-index.htm |
| 2019-05-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001091/0001279569-19-001091-index.htm |
| 2019-06-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001397/0001279569-19-001397-index.htm |
| 2019-06-24 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001422/0001279569-19-001422-index.htm |
| 2019-07-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001582/0001279569-19-001582-index.htm |
| 2019-08-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001634/0001279569-19-001634-index.htm |
| 2019-08-02 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001640/0001279569-19-001640-index.htm |
| 2019-08-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001654/0001279569-19-001654-index.htm |
| 2019-08-02 | SUPPL | Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001660/0001279569-19-001660-index.htm |
| 2019-08-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001662/0001279569-19-001662-index.htm |
| 2019-08-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001680/0001279569-19-001680-index.htm |
| 2019-08-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001709/0001279569-19-001709-index.htm |
| 2019-08-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001738/0001279569-19-001738-index.htm |
| 2019-08-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001744/0001279569-19-001744-index.htm |
| 2019-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001773/0001279569-19-001773-index.htm |
| 2019-08-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001776/0001279569-19-001776-index.htm |
| 2019-09-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001856/0001279569-19-001856-index.htm |
| 2019-09-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001866/0001279569-19-001866-index.htm |
| 2019-09-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001922/0001279569-19-001922-index.htm |
| 2019-09-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919001993/0001279569-19-001993-index.htm |
| 2019-11-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919002248/0001279569-19-002248-index.htm |
| 2019-11-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919002274/0001279569-19-002274-index.htm |
| 2019-11-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919002330/0001279569-19-002330-index.htm |
| 2019-11-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919002331/0001279569-19-002331-index.htm |
| 2019-11-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919002360/0001279569-19-002360-index.htm |
| 2019-11-25 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919002395/0001279569-19-002395-index.htm |
| 2019-12-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919002474/0001279569-19-002474-index.htm |
| 2019-12-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919002475/0001279569-19-002475-index.htm |
| 2019-12-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919002480/0001279569-19-002480-index.htm |
| 2019-12-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956919002519/0001279569-19-002519-index.htm |
| 2020-01-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000110/0001279569-20-000110-index.htm |
| 2020-03-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000235/0001279569-20-000235-index.htm |
| 2020-03-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000274/0001279569-20-000274-index.htm |
| 2020-03-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000314/0001279569-20-000314-index.htm |
| 2020-03-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000369/0001279569-20-000369-index.htm |
| 2020-03-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000425/0001279569-20-000425-index.htm |
| 2020-03-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000431/0001279569-20-000431-index.htm |
| 2020-04-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000496/0001279569-20-000496-index.htm |
| 2020-04-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000564/0001279569-20-000564-index.htm |
| 2020-05-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000649/0001279569-20-000649-index.htm |
| 2020-05-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000659/0001279569-20-000659-index.htm |
| 2020-05-06 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000680/0001279569-20-000680-index.htm |
| 2020-05-18 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000800/0001279569-20-000800-index.htm |
| 2020-05-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000127956920000824/0001279569-20-000824-index.htm |
| 2020-05-27 | F-10POS | Post-effective amendment to a F-10EF registration | https://www.sec.gov/Archives/edgar/data/1036141/000134100420000223/0001341004-20-000223-index.htm |
| 2020-05-27 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1036141/000134100420000224/0001341004-20-000224-index.htm |
| 2020-05-27 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1036141/000134100420000225/0001341004-20-000225-index.htm |
| 2020-05-27 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1036141/000134100420000226/0001341004-20-000226-index.htm |
| 2020-05-27 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1036141/000134100420000227/0001341004-20-000227-index.htm |
| 2020-05-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1036141/000134100420000228/0001341004-20-000228-index.htm |
| 2020-06-09 | 15-12G | Securities registration termination [Section 12(g)] | https://www.sec.gov/Archives/edgar/data/1036141/000134100420000241/0001341004-20-000241-index.htm |
| 2020-05-27 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret | https://www.sec.gov/Archives/edgar/data/1036141/000135445720000204/0001354457-20-000204-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000142157819000011/0001421578-19-000011-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1036141/000142157820000007/0001421578-20-000007-index.htm |
| 2018-07-06 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1036141/999999999518001723/9999999995-18-001723-index.htm |
| 2020-05-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1036141/999999999520001258/9999999995-20-001258-index.htm |
| 2020-05-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1036141/999999999520001264/9999999995-20-001264-index.htm |
| 2018-08-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1036141/999999999718007353/9999999997-18-007353-index.htm |